Gleolan, a dye used for brain imaging, can help surgeons visualize tumor tissue during surgery for glioblastoma multiforme. Malignant transformation occurs from aggregation of genetic alterations and ...
The glioblastoma multiforme market is expected to witness a significant positive shift owing to the positive outcomes of several products during the developmental stage by key players such as Avita ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to WP1122 for the treatment of glioblastoma multiforme, according to a ...
BPM31510 is a first-in-class therapeutic targeting tumor metabolism to re-program mitochondrial microenvironment in Warburg-avid tumorsBoth ...
WORLD BRAIN TUMOUR DAYGet breaking news anytime, anywhere. Download the TOI app now!Patna: Advances in awareness and medical care are driving a 30%-40% increase in the early diagnosis of brain tumours ...
Scientists at the Fralin Biomedical Research Institute at VTC have identified a new zebrafish model that could help advance glioblastoma multiforme research. Glioblastoma is an aggressive form of ...
After exhausting standard treatment options for Grade 4 glioblastoma in Canada, Ronald and his wife Freya traveled to Germany ...
Patients’ experience and physicians strategies for selection of anthracyclines and taxanes sequential treatment in adjuvant breast cancer: The Violayne prospective multicenter survey. Efficacy of ...
Acute toxicity profile of patients with low-grade gliomas and meningiomas receiving proton therapy. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include ...
Novel combination therapy with STAR-001 targets the most aggressive and deadliest forms of brain cancer at first progression GBM represents an annual market opportunity of $3 to $5 billion USD with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results